Skip Page Header

Home > Clinical question: How do different smoking reduction interventions compare in terms of long‐term (≥ 6 months) smoking cessation?

Ciapponi, Agustín [The Cochrane Library] . (2020) Clinical question: How do different smoking reduction interventions compare in terms of long‐term (≥ 6 months) smoking cessation? Cochrane Clinical Answers DOI: 10.1002/cca.2994

URL: https://www.cochranelibrary.com/cca/doi/10.1002/cc...

Moderate‐certainty evidence shows that reduction to quit compared with abrupt quitting may result in little to no difference in smoking cessation at ≥ 6‐month follow‐up. Compared with no smoking cessation intervention, the effect of reduction to quit (by face‐to‐face sessions and/or calls) on smoking abstinence is very uncertain, although absolute numbers quitting appear to be low in both groups (on average, ≤ 6%). Low‐certainty evidence suggests that, compared with reduction to quit alone, reduction to quit plus pharmacotherapy can result in slightly more people with long‐term smoking abstinence (on average, 36 vs 21 per 1000 people). When different types of pharmacotherapy were assessed individually, varenicline showed the greatest benefit (on average, 239 vs 60 per 1000 people; moderate‐certainty evidence).


Item Type
International research
Publication Type
Guideline
Drug Type
Tobacco / Nicotine
Intervention Type
Drug therapy, Treatment method, Psychosocial treatment method
Date
26 March 2020
EndNote

Repository Staff Only: item control page